Transplant News and Research

RSS

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Verastem, Inc., focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the National Comprehensive Cancer Network added COPIKTRA (duvelisib) capsules to the Clinical Practice Guidelines in Oncology (NCCN Guidelines) for follicular lymphoma.

8 Oct 2018

Study shows possibility of using PET imaging to manage chronic liver diseases

While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject to complications. These effects may soon be a thing of the past for some patients thanks to new research showing PET imaging with the 18F-FAC radiotracer can be used as a non-invasive substitute. The study is featured in the October issue of The Journal of Nuclear Medicine.

5 Oct 2018

Gut microbiome appears to play key role in heart transplant outcomes

In a new study, researchers at the University of Maryland School of Medicine have found that the gut microbiome appears to play a key role in how well the body accepts a transplanted heart. The scientists found a causal relationship between the presence of certain microbes and transplant outcome.

4 Oct 2018

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today updated positive results from its Phase 1/2 clinical study of lumasiran, an investigational, subcutaneously administered RNAi therapeutic targeting glycolate oxidase for the treatment of primary hyperoxaluria type 1.

4 Oct 2018

Wits doctors transplant liver from HIV positive mother to her child with end-stage liver disease

This was the ethical dilemma faced by doctors at Wits Donald Gordon Medical Centre to save a child's life.

4 Oct 2018

Liver transplant and weight-loss surgery combination offers long-term benefits to obese patients

Obese patients who underwent a life-saving liver transplant and weight-loss surgery at the same time were better able to keep the weight off long term and had fewer metabolic complications than those who lost weight on their own before undergoing a liver transplant, Mayo Clinic research shows.

3 Oct 2018

Researchers caution that expediting HLH treatment may miss underlying cancers

Physicians who specialize in a devastating and aggressive immune disorder called hemophagocytic lymphohistiocytosis report in a new study that extra care should be taken to ensure an HLH diagnosis doesn't obscure possible underlying cancers.

1 Oct 2018

New analysis confirms value of minimal residual disease as prognostic indicator in multiple myeloma

Adaptive Biotechnologies today announced that Blood, the Journal of the American Society of Hematology, published online an analysis of patient samples from the Intergroupe Francophone du Myéloma 2009 trial.

1 Oct 2018

MTF Biologics introduces Flexhd Pliable PRE for pre-pectoral breast reconstruction

MTF Biologics is expanding its portfolio of innovations for post-mastectomy breast reconstruction with the launch of an acellular dermal matrix designed specifically for pre-pectoral breast reconstruction procedures: FlexHD Pliable PRE.

1 Oct 2018

Novel discovery could help to improve success of corneal transplants

A team of eye specialists at The University of Nottingham has made another novel discovery that could help to improve the success of corneal transplants for patients whose sight has been affected by disease.

1 Oct 2018

New project aims to develop strategies for more durable animal-derived heart valves

Animal-derived heart valves are preferred to mechanical ones for valve-replacement heart surgery because they are more biocompatible and do not require a life-changing regime of anticoagulant drugs.

29 Sep 2018

Cidara initiates Phase 3 clinical trial to evaluate efficacy, safety of rezafungin to treat invasive candidiasis

Cidara Therapeutics, Inc., a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the first trial site has been activated for ReSTORE, a Phase 3 clinical trial evaluating the efficacy and safety of the company's lead antifungal, rezafungin, to treat candidemia and invasive candidiasis.

27 Sep 2018

CytoSen receives favorable response from FDA to its pre-IND meeting package for CSTD002-NK

CytoSen Therapeutics, a private biopharmaceutical company accelerating innovation in Natural Killer cell therapy, today announced it has received a favorable response from the U.S. Food and Drug Administration to its pre-Investigational New Drug meeting package for the proposed Phase 2 trial of CytoSen's adoptive NK cell therapy, CSTD002-NK, for the reduction of relapse in high risk acute myeloid leukemia or myelodysplastic syndrome in patients undergoing haploidentical hematopoietic stem cell transplantation.

27 Sep 2018

CIRM approves $1.6M grant to help bring human islet-like organoids to diabetic patients

Approximately 1.25 million Americans are living with type 1 diabetes, with an additional 40,000 people newly diagnosed every year.

27 Sep 2018

Mapping the trillion cells in the human body

The human body is made up of 100 trillion cells and a team of scientists are now planning on cataloguing and imaging each of these cells in the body and creating a 3D human body map.

26 Sep 2018

New approach for bone marrow transplant could make it safer and more effective for patients

Two recent studies in the journal Leukemia present a new approach for bone marrow donation and transplant that preclinical laboratory tests suggest could make the life-saving procedure safer and more effective for patients.

26 Sep 2018

Mesoblast’s MPC therapy for children featured at symposium for congenital heart disease

Mesoblast Limited today announced that Mesoblast's proprietary allogeneic mesenchymal precursor cell heart failure product candidate MPC-150-IM for use in children with hypoplastic left heart syndrome was featured at the First Cardiac Regenerative Symposium for Congenital Heart Disease in Baltimore, Maryland on the weekend.

26 Sep 2018

Organs actively fighting back against autoimmune diseases, finds study

Organs affected by autoimmune disease could be fighting back by "exhausting" immune cells that cause damage using methods similar to those used by cancer cells to escape detection, according to a study by researchers at the University of Pittsburgh School of Medicine published today in the Journal of Clinical Investigation.

25 Sep 2018

National Eye Health Week 2018: Paralympic medalists support Fight for Sight’s unique virtual event

Paralympic medallists are supporting Fight for Sight’s massive adventure on a small scale, with the launch of a unique virtual event today for National Eye Health Week 2018.

24 Sep 2018

Study reveals promising new drug candidate to treat acute renal failure

A protein produced by the human body appears to be a promising new drug candidate to treat conditions that lead to acute renal failure. This is shown by a study conducted at São Paulo State University in São José do Rio Preto, Brazil.

20 Sep 2018

Transplant News and Research

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Study shows possibility of using PET imaging to manage chronic liver diseases

Gut microbiome appears to play key role in heart transplant outcomes

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Wits doctors transplant liver from HIV positive mother to her child with end-stage liver disease

Liver transplant and weight-loss surgery combination offers long-term benefits to obese patients

Researchers caution that expediting HLH treatment may miss underlying cancers

New analysis confirms value of minimal residual disease as prognostic indicator in multiple myeloma

MTF Biologics introduces Flexhd Pliable PRE for pre-pectoral breast reconstruction

Novel discovery could help to improve success of corneal transplants

New project aims to develop strategies for more durable animal-derived heart valves

Cidara initiates Phase 3 clinical trial to evaluate efficacy, safety of rezafungin to treat invasive candidiasis

CytoSen receives favorable response from FDA to its pre-IND meeting package for CSTD002-NK

CIRM approves $1.6M grant to help bring human islet-like organoids to diabetic patients

Mapping the trillion cells in the human body

New approach for bone marrow transplant could make it safer and more effective for patients

Mesoblast’s MPC therapy for children featured at symposium for congenital heart disease

Organs actively fighting back against autoimmune diseases, finds study

National Eye Health Week 2018: Paralympic medalists support Fight for Sight’s unique virtual event

Study reveals promising new drug candidate to treat acute renal failure

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News